
The head of France’s data privacy said on Wednesday she was considering triggering the process of fining US-based Clearview AI, a facial recognition company the regulator had ordered to stop amassing data from people based in the country.
The start of a formal penalty process would indicate that CNIL suspected Clearview of failing to comply with its order within the two-month deadline it had set.
“I am seriously thinking about it,” Marie-Laure Denis said, after presenting CNIL’s annual report.
In a formal demand disclosed last December, the regulator said Clearview’s collection of publicly-available facial images on social media and the internet breached European Union rules on data privacy, known as GDPR.
Under EU law, the regulatory framework of the GDPR can apply in some cases where data of EU-based users of internet services are tracked and processed, even if the provider has no physical presence inside the bloc.
CNIL said in December that the software company, which is used as a search engine for faces to help law enforcement and intelligence agencies in their investigations, failed to ask for the prior consent of those whose images it collected online.
Denis did not elaborate on the extent of the potential fine that the regulator could issue.
Clearview agreed earlier this week to restrictions on how businesses can use its database of billions of facial images, to resolve a US lawsuit that accused it of collecting people’s photos without permission.
Critics of Clearview AI have said its technology violated people’s privacy. The company has said blocking it from using publicly-available images amounted to censorship.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas